Showing 351-360 of 2444 results for "".
Paraclinical Optic Nerve Tests in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/paraclinical-optic-nerve-tests-in-multiple-sclerosis/54605/Confirming optic neuritis—and, by extension, optic nerve involvement as a distinct anatomic region within the McDonald criteria—requires careful integration of the individual’s history, a thorough neuro-ophthalmic examination, and judicious interpretation of diagnostic tests.How to Know it When You See It: Diagnosing Neuralgic Amyotrophy (Parsonage-Turner Syndrome)
https://practicalneurology.com/diseases-diagnoses/neuromuscular/how-to-know-it-when-you-see-it-diagnosing-neuralgic-amyotrophy-parsonage-turner-syndrome/30513/An understanding of the basic science, clinical presentation, and treatment options for neuralgic amyotrophy is necessary to facilitate timely diagnosis and treatment.News
https://practicalneurology.com/columns/practice-management/news/30537/An Algorithmic Approach to Headache With Fever
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-algorithmic-approach-to-headache-with-fever/54600/Headache accompanied by fever can indicate a wide range of disorders, making prompt and comprehensive evaluation crucial to identify the underlying cause and guide appropriate management for better patient outcomes.Update on Noninvasive Neuromodulation Devices for Headache Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/update-on-noninvasive-neuromodulation-devices-for-headache-treatment/32129/Neuromodulation devices are effective in primary headache management, present low risk, and have minimal to no adverse events but require an understanding of how they can be integrated into the therapeutic armamentarium.Movement Disorders Moment: Environmental and Biologic Risk and Protective Factors Associated with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-momentbrenvironmental-and-biologic-risk-and-protective-factors-associated-with-parkinson-disease/32120/This review provides a concise summary of the evidence for environmental and biologic risk and protective factors for Parkinson disease.Inclusive Research for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/inclusive-research-for-multiple-sclerosis/31755/Inclusive research improves quality of scientific data, facilitates discovery of safety and efficacy, and assists in identifying population-specific differences.Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Bruton Tyrosine Kinase Inhibition in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/bruton-tyrosine-kinase-inhibition-in-multiple-sclerosis/31872/The missing link for treatment optimization?Addressing Alzheimer's Disease: Target 2025
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/addressing-alzheimers-disease-target-2025/30631/The Alzheimer's Association takes an in-depth look at the US National Plan to Address Alzheimer's Disease, which seeks to prevent and effectively treat Alzheimer's disease by 2025.